JAMA

Risk-Based vs Annual Breast Cancer Screening: The WISDOM Randomized Clinical Trial

Cancer Treatment Reviews

Mechanisms and biomarkers for musculoskeletal signs and symptoms in patients treated with aromatase inhibitors: A comprehensive systematic review

The Breast

Genomic landscape of metastatic breast cancers in young adults: A liquid biopsy analysis of women aged 20-40 years

The American Surgeon

Assessing nodal positivity in men 70 years of age and older with clinically node negative hormone-receptor positive breast cancer to guide axillary intervention

Clinical Cancer Research

Real-world outcomes of elacestrant in ER+, HER2−, ESR1-mutant metastatic breast cancer

Clinical Cancer Research

The prognostic and predictive impact of ctDNA levels in patients with advanced breast cancer enrolled on the plasmaMATCH trial

Clinical Cancer Research

Clinical and genomic factors associated with elacestrant outcomes in ESR1-mutant metastatic breast cancer open access

ESMO Open

A phase IV prospective study of efficacy and safety of ribociclib and letrozole as first-line therapy in older women (≥70 years) with hormone receptor-positive HER2-negative advanced breast cancer: The RibOB study

Cancer Research and Treatment

Pre-treatment Ki67 index for everolimus efficacy in patients with hormone receptor-positive and human epidermal growth factor receptor 2-negative advanced breast cancer: A multicenter cohort study

Breast Cancer Research

Multiomic profiling of ER-positive HER2-negative breast cancer reveals markers associated with metastatic spread